Published in Eur J Endocrinol on March 01, 2007
Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care (2010) 2.52
Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets. J Clin Invest (2012) 1.40
Prognostic relevance of hypoglycemia following an oral glucose challenge for cystic fibrosis-related diabetes. Diabetes Care (2011) 0.80
Quantifying insulin sensitivity and entero-insular responsiveness to hyper- and hypoglycemia in ferrets. PLoS One (2014) 0.79
Hypoglycemia in adults with cystic fibrosis during oral glucose tolerance testing. Diabetes Care (2013) 0.76
The genome sequence of the plant pathogen Xylella fastidiosa. The Xylella fastidiosa Consortium of the Organization for Nucleotide Sequencing and Analysis. Nature (2000) 10.03
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology (1997) 3.10
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut (2002) 1.98
Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr (1994) 1.76
Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion. J Am Coll Cardiol (2001) 1.63
Linkage disequilibrium between cystic fibrosis and linked DNA polymorphisms in Italian families: a collaborative study. Am J Hum Genet (1988) 1.60
Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients. Eur J Endocrinol (2011) 1.60
Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol (2011) 1.59
Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54
Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry (1999) 1.53
Primary lactase deficiency and past malarial endemicity in Sardinia. Ital J Gastroenterol Hepatol (1998) 1.52
Sequencing and functional analysis of styrene catabolism genes from Pseudomonas fluorescens ST. Appl Environ Microbiol (1997) 1.45
Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism. Hepatology (1991) 1.43
[Recommendations on hypertension in children: the CHI/d project]. Pediatr Med Chir (2005) 1.42
The contribution of sublingual immunotherapy to the achievement of control in birch-related mild persistent asthma: a real-life randomised trial. Allergol Immunopathol (Madr) (2012) 1.41
Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis. Aliment Pharmacol Ther (2007) 1.40
Single-strand conformation polymorphism analysis of the glucose transporter gene GLUT1 in maturity-onset diabetes of the young. J Mol Med (Berl) (2001) 1.39
Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis (2005) 1.35
Enzyme release from polymorphonuclear leukocyte lysosomes: regulation by autonomic drugs and cyclic nucleotides. Science (1973) 1.34
Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry (1998) 1.29
Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Medicine (Baltimore) (1985) 1.23
[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry (1995) 1.23
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol (2001) 1.21
Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone. Gastroenterology (1989) 1.21
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology (1997) 1.20
The detection of monocytes in human glomerulonephritis. Kidney Int (1985) 1.17
Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group. Ann Oncol (2013) 1.16
Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med (1986) 1.15
Permanent diabetes during the first year of life: multiple gene screening in 54 patients. Diabetologia (2011) 1.15
Acute liver and renal failure during treatment with buprenorphine at therapeutic dose. Dig Liver Dis (2008) 1.14
Body composition assessment in spinal cord injury subjects. Acta Diabetol (2003) 1.11
Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients. Genes Brain Behav (2007) 1.10
Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile. J Biol Chem (1988) 1.09
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. J Hepatol (2001) 1.09
Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology (1996) 1.06
Liver and biliary problems in cystic fibrosis. Semin Liver Dis (1998) 1.06
Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr (1990) 1.06
No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes. Diabetologia (2011) 1.05
Sleep loss, a possible factor in augmenting manic episode. Psychiatry Res (1996) 1.03
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology (1991) 1.02
Enzyme release from guinea-pig polymorphonuclear leucocyte lysosomes inhibited in vitro by anti-inflammatory drugs. Nat New Biol (1972) 1.02
Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol (2011) 1.02
Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin Exp Immunol (1998) 1.02
Pharmacokinetics of anticancer agents in patients with impaired liver function. Eur J Cancer (1998) 1.02
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut (2006) 1.01
Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol (2000) 1.01
Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res (1992) 1.01
Presence of fibronectin in articular cartilage in two animal models of osteoarthritis. J Rheumatol (1986) 1.00
Ileal carcinoid metastatic to the breast. Report of a case. Tumori (1988) 1.00
Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy. Am J Hum Genet (1991) 1.00
Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis. Pediatr Infect Dis J (1987) 0.99
Frequency of the delta F508 mutation in a sample of 175 Italian cystic fibrosis patients. Hum Genet (1990) 0.99
Bridge to lung transplantation by venovenous extracorporeal membrane oxygenation: a lesson learned on the first four cases. Transplant Proc (2010) 0.98
Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects. Br J Clin Pharmacol (2004) 0.98
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. Hepatology (1992) 0.98
Molecular and clinical features associated with CFTR gene rearrangements in Italian population: identification of a new duplication and recurrent deletions. Clin Genet (2008) 0.97
Drug prescriptions in liver and biliary disease: something more to be done. Ital J Gastroenterol Hepatol (1998) 0.97
Morning sunlight reduces length of hospitalization in bipolar depression. J Affect Disord (2001) 0.97
Association of the CLCA1 p.S357N variant with meconium ileus in European patients with cystic fibrosis. J Pediatr Gastroenterol Nutr (2010) 0.95
Biliary bile acid composition of the human fetus in early gestation. Pediatr Res (1987) 0.94
Jagged-1 mutation analysis in Italian Alagille syndrome patients. Hum Mutat (1999) 0.94
Severe nephropathy in three adolescents with cystic fibrosis. Arch Dis Child (1991) 0.93
The unipolar-bipolar dichotomy and the response to sleep deprivation. Psychiatry Res (1998) 0.93
Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology (1990) 0.92
Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. Gut (1996) 0.92
Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models. Biochim Biophys Acta (1988) 0.92
Response to SSRIs and role of the hormonal therapy in post-menopausal depression. Eur Neuropsychopharmacol (2006) 0.92
A new in vivo assay for screening drugs for potential anti-inflammatory activity. J Clin Pharmacol J New Drugs (1967) 0.92
Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology (1999) 0.92
Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology (1990) 0.90
Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration. J Lipid Res (2001) 0.90
Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial. Neuropsychopharmacology (1999) 0.90
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy. J Med Virol (1998) 0.90
Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency. J Pediatr Gastroenterol Nutr (1984) 0.89
Contribution of weight cycling to serum leptin in human obesity. Int J Obes Relat Metab Disord (2001) 0.89
A new model of osteoarthritis in rabbits. III. Evaluation of anti-osteoarthritic effects of selected drugs administered intraarticularly. Arthritis Rheum (1983) 0.89
Sleep phase advance and lithium to sustain the antidepressant effect of total sleep deprivation in bipolar depression: new findings supporting the internal coincidence model? J Psychiatr Res (2001) 0.88
The occurrence of percutaneous injuries to health care workers: a cross sectional survey in seven Swiss hospitals. Schweiz Med Wochenschr (1998) 0.88
Hemolytic uremic syndrome and cattle. Clin Nephrol (2003) 0.88
Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study. Aliment Pharmacol Ther (1997) 0.87
Circadian clock gene Per3 variants influence the postpartum onset of bipolar disorder. Eur Psychiatry (2011) 0.87